1 ANNEX "B" SEVERANCE COMPENSATION AGREEMENT SEVERANCE COMPENSATION AGREEMENT (the "Agreement") dated as of April 14, 1999, by and between ZymeTx, Inc., a Delaware corporation (the "Company"), and Peter G. Livingston (the "Executive"). WHEREAS, the...Severance Compensation Agreement • October 13th, 1999 • Zymetx Inc • In vitro & in vivo diagnostic substances • Oklahoma
1 AMENDMENT NO. 1 TOExecutive Services Agreement • October 13th, 1999 • Zymetx Inc • In vitro & in vivo diagnostic substances
1. Building: 800 Research Parkway Building 1, Oklahoma City, OK 2. Amended Lease Premises: The Leased Premises will change to include all of the 1st floor consisting of approximately 22,833 rentable square feet (RSF) and all of the 2nd floor...Zymetx Inc • October 13th, 1999 • In vitro & in vivo diagnostic substances
1 SEVERANCE COMPENSATION AGREEMENT SEVERANCE COMPENSATION AGREEMENT (the "Agreement") dated as of April 14, 1999, by and between ZymeTx, Inc., a Delaware corporation (the "Company"), and Gary W. Pedersen (the "Executive"). WHEREAS, the Company's Board...Severance Compensation Agreement • October 13th, 1999 • Zymetx Inc • In vitro & in vivo diagnostic substances • Oklahoma
